Suchergebnisse - "A Banerjee"

PubPharm (56)

1

Exploring the binding interactions of NOP receptor with designed natural phytochemical-neuropeptide conjugates: an in silico and SPR study

in: Applied Biological Chemistry | 2024

von Molly E. Murray | Beatriz G. Goncalves | Mary A. Biggs | +3

2

Climate sensitivity of the summer runoff of two glacierised Himalayan catchments with contrasting climate

in: Hydrology and Earth System Sciences | 2023

von S. Laha | S. Laha | A. Banerjee | +3

3

Probing the Interactions of LRP1 Ectodomain-Derived Peptides with Fibrillar Tau Protein and Its Impact on Cellular Internalization

in: Applied Sciences | 2023

von E. Josephine Boder | Beatriz G. Goncalves | Charlotta G. Lebedenko | +1

4

P32 MAJESTEC-1: CORRELATIVE ANALYSES OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)

in: HemaSphere | 2023

von N. van de Donk | D. Cortes-Selva | T. Casneuf | +22

5

Predictors of self-management in patients with chronic low back pain: a longitudinal study

in: BMC Musculoskeletal Disorders | 2022

von A. Banerjee | P. Hendrick | H. Blake

6

The roles of the Quasi-Biennial Oscillation and El Niño for entry stratospheric water vapor in observations and coupled chemistry–ocean CCMI and CMIP6 models

in: Atmospheric Chemistry and Physics | 2022

von S. Ziskin Ziv | S. Ziskin Ziv | C. I. Garfinkel | +3

7

P961: CILTACABTAGENE AUTOLEUCEL, A BCMA-DIRECTED CAR-T CELL THERAPY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: 2-YEAR POST LPI RESULTS FROM THE PHASE 1B/2 CARTITUDE-1 STUDY

in: HemaSphere | 2022

von Y. Lin | T. Martin | J. G. Berdeja | +17

8

P06: UPDATED RESULTS FROM THE PHASE 1/2 MAJESTEC-1 STUDY OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

in: HemaSphere | 2022

von R Popat | S Usmani | A Garfall | +29

9

In Silico Studies of Tumor Targeted Peptide-Conjugated Natural Products for Targeting Over-Expressed Receptors in Breast Cancer Cells Using Molecular Docking, Molecular Dynamics and MMGBSA Calculations

in: Applied Sciences | 2022

von Lucy R. Hart | Charlotta G. Lebedenko | Saige M. Mitchell | +2

10

P921: UPDATED EFFICACY AND SAFETY RESULTS OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM MAJESTEC-1

in: HemaSphere | 2022

von J. Martínez-López | P. Moreau | S. Z. Usmani | +17

1
2
3
4
5
6
Nächster »
[6]